Share on StockTwits

Mednax (NYSE:MD) SVP Dominic J. Andreano unloaded 2,252 shares of the company’s stock on the open market in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $58.48, for a total value of $131,696.96. Following the completion of the transaction, the senior vice president now directly owns 20,391 shares in the company, valued at approximately $1,192,466. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Several analysts have recently commented on the stock. Analysts at Dougherty & Co raised their price target on shares of Mednax from $63.00 to $66.00 in a research note on Monday, May 5th. They now have a “buy” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Mednax in a research note on Thursday, April 17th. They now have a $69.00 price target on the stock. Finally, analysts at Deutsche Bank upgraded shares of Mednax from a “hold” rating to a “buy” rating in a research note on Tuesday, April 1st. They now have a $73.00 price target on the stock, up previously from $57.00. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Mednax currently has a consensus rating of “Buy” and a consensus target price of $83.40.

Mednax (NYSE:MD) traded up 0.24% on Tuesday, hitting $58.80. The stock had a trading volume of 342,556 shares. Mednax has a 52 week low of $43.565 and a 52 week high of $64.51. The stock has a 50-day moving average of $57.94 and a 200-day moving average of $57.68. The company has a market cap of $5.826 billion and a price-to-earnings ratio of 20.51.

Mednax (NYSE:MD) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.63 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.63. The company had revenue of $566.00 million for the quarter, compared to the consensus estimate of $574.80 million. During the same quarter in the prior year, the company posted $1.10 earnings per share. The company’s quarterly revenue was up 12.7% on a year-over-year basis. Analysts expect that Mednax will post $3.16 EPS for the current fiscal year.

MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.